This is an observational study for people with cancer who also have mucormycosis (a serious fungal infection), invasive aspergillosis, bacterial pneumonia, or are at risk for fungal infections. The study aims to collect information and samples from you, such as blood and tissue, as part of your regular medical care. Researchers will also review your medical records. The goal is to better understand these infections and how they affect people with cancer. Your participation involves telling the study team about any symptoms or side effects, following study directions, and attending all appointments. This study plans to enroll 300 participants aged 18 to 100 years old. The main thing being looked at is your safety and any side effects you might experience throughout the study, which is expected to last about one year.

Study design

This is an observational study, meaning you will be assigned to one of four groups based on your condition. It plans to enroll 300 participants.

What's involved

You would tell the study team about any symptoms or side effects, follow study directions, and come to all study appointments (or reschedule). You would also undergo routine diagnostic procedures like blood draws, bronchoscopy, or biopsy as part of your regular care.

Compensation

Not stated in the trial record.

Follow-up

Your safety and any adverse events will be measured through study completion, which is an average of one year.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.